Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore to Present at AusBiotech 2020
Anatara's CEO, Steve Lydeamore will be presenting to investors at AusBiotech + Invest 2020 on 29th October 2020. Register to attend free for qualified investors.
Companies in the News
Drugs & OTC
Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation
Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today at the ASX Small and Mid-Cap Conference 2020, a virtual conference.
Anatara Lifesciences (ASX:ANR) ASX Small and Mid-Cap Conference 2020
Steven Lydeamore, Chief Executive Officer, Anatara Lifesciences (ASX:ANR) will be presenting at the ASX Small and Mid-Cap Conference 2020.
Anatara Lifesciences Ltd (ASX:ANR) Financial Report 30 June 2020
Anatara Lifesciences (ASX:ANR) today released its Appendix 4E and review of operations for the period ending 30 June 2020.
Anatara Lifesciences Ltd (ASX:ANR) Animal Health Update
Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide an update on initiation of challenge study in poultry with the recently developed bromelain-based formulation (ANR-pf).
Cann Global Limited (ASX:CGB) Quarterly Activities and Cashflow Report
Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales.
Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report
While focussing financial resources on development of GaRP, Anatara has been evaluating development, in collaboration with third parties, additional dosage forms for piglets and to utilise Anatara's intellectual property in other species including in-feed formulations for piglets, formulations for aquaculture and formulations for poultry.
◂Previous Page
Drugs & OTC Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
- Basin Energy Ltd (ASX:BSN) Completes Phase One Drilling and Expands Sybella-Barkly
- Deep Yellow Limited (ASX:DYL) Tumas Project Update
- Central Petroleum Limited (ASX:CTP) LOI Signed for New Drilling and Long-Term Gas Supply
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
- BPH Energy Limited (ASX:BPH) Chair's Address to Shareholders
Social Media
